ADC Therapeutics S.A.
ADCT | NYSE
$1.22
+$0.10 (+8.93%)
Sep 22, 2026, 11:17 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -3.15 | -1.23 | -0.56 | -1.93 | -6.73 | -8.49 |
PEG Ratio | 0.10 | 0.03 | -0.01 | 0.06 | 0.33 | -0.07 |
PS Ratio | 5.51 | 2.73 | 1.95 | 1.43 | 45.71 | n/a |
PB Ratio | -2.41 | -0.95 | -0.91 | 3.78 | 9.33 | 6.24 |
P/FCF Ratio | -3.17 | -1.55 | -1.11 | -2.18 | -6.47 | -12.21 |
P/OCF Ratio | -3.18 | -1.56 | -1.14 | -2.19 | -6.64 | -12.41 |
OCF/S Ratio | -173.52 | -174.82 | -170.63 | -65.17 | -688.09 | n/a |
Debt / Equity Ratio | -2.36 | -0.61 | -0.84 | 1.63 | 0.84 | 0.34 |
Quick Ratio | 4.31 | 3.59 | 4.73 | 5.16 | 6.95 | 11.14 |
Current Ratio | 4.37 | 3.82 | 4.97 | 5.31 | 7.10 | 11.14 |
Asset Turnover | 0.25 | 0.22 | 0.20 | 0.43 | 0.05 | n/a |
Interest Coverage | -2.10 | -2.60 | -3.58 | -3.36 | -14.27 | -44.51 |
Return on Equity | 76.75% | 77.89% | 161.93% | -197.77% | -138.50% | -73.41% |
Return on Assets | -44.14% | -49.02% | -67.66% | -32.01% | -37.22% | -47.95% |
Return on Invested Capital | -42.29% | -53.79% | -57.52% | -29.19% | -43.39% | -45.88% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 90.57% | 91.60% | 96.36% | 98.43% | 95.89% | n/a |
Net Profit Margin | -175.31% | -222.83% | -345.11% | -74.86% | -678.20% | n/a |
Pretax Profit Margin | -175.50% | -222.60% | -288.89% | -74.75% | -741.53% | n/a |
Operating Profit Margin | -133.21% | -184.44% | -238.63% | -58.76% | -771.65% | n/a |
FCF Margin | -173.85% | -176.04% | -175.25% | -65.44% | -706.88% | n/a |
EBITDA Margin | -109.73% | -144.91% | -209.65% | -51.31% | -679.70% | n/a |
Add to Watchlist
Select watchlists to add or remove ADCT